$0.5955+0.42%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Outlook Therapeutics last closed at $0.5955 (+0.42%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -0.2×. Its overall grade ranks 192 of 741 stocks in Healthcare.
About this company
Outlook Therapeutics last closed at $0.5955 (+0.42%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A- · 192/741
Valuation grade A-
Related stocks
- Regeneron PharmaceuticalsCompetitor
안과용 바이오의약품 개발·상업화 분야의 주요 경쟁사
- NovartisCompetitor
안과 질환 치료제 및 망막질환 치료 영역의 글로벌 경쟁사
- RocheCompetitor
망막질환·안과 바이오의약품 시장에서 경쟁하는 대형 제약사
About Outlook Therapeutics
- What technical signals does Outlook Therapeutics (OTLK) have?
- Outlook Therapeutics current technical signals: no active technical signal.
- Is Outlook Therapeutics a cup-and-handle pattern?
- No. Outlook Therapeutics has no valid Cup signal right now.
- What published figures are available for Outlook Therapeutics?
- Market cap: $38.18M. Trailing 12 months PER: -0.2×. Latest quarter PBR: -1.46×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Outlook Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy